Capital Expenditures for Charles River (CRL)
According to Charles River's latest reported financial statements, the company's current capital expenditures (TTM) is $219.15M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingCapital ExpendituresSwitch metric
Latest period
$219.15M
YoY change
-5.9%
5Y CAGR
+5.6%
Peak year (2022)
$324.73M
Cumulative capital expenditures
$3.18B
CapEx history chart for Charles River (CRL) from 1998 to 2025
CapEx history table for Charles River (CRL) from 1998 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $219.15M | -5.9% | ||
| 2024 | $232.97M | -26.9% | ||
| 2023 | $318.53M | -1.9% | ||
| 2022 | $324.73M | +41.9% | ||
| 2021 | $228.77M | +37.4% | ||
| 2020 | $166.56M | +18.5% | ||
| 2019 | $140.51M | +0.3% | ||
| 2018 | $140.05M | +69.9% | ||
| 2017 | $82.43M | +49.1% | ||
| 2016 | $55.29M | -12.6% | ||
| 2015 | $63.25M | +11.1% | ||
| 2014 | $56.92M | +45.4% | ||
| 2013 | $39.15M | -17.6% | ||
| 2012 | $47.53M | -3.3% | ||
| 2011 | $49.14M | +14.7% | ||
| 2010 | $42.86M | -46.4% | ||
| 2009 | $80.01M | -59.4% | ||
| 2008 | $197.08M | -13.2% | ||
| 2007 | $227.04M | +24.9% | ||
| 2006 | $181.75M | +90.2% | ||
| 2005 | $95.55M | +110.8% | ||
| 2004 | $45.34M | +38.6% | ||
| 2003 | $32.70M | -12.9% | ||
| 2002 | $37.54M | +2.4% | ||
| 2001 | $36.66M | +135.5% | ||
| 2000 | $15.56M | +20.2% | ||
| 1999 | $12.95M | +8.7% | ||
| 1998 | $11.91M | — |
CapEx values are taken from Charles River's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Charles River (CRL) most recent annual capital expenditures stands at $219.15M (2025) – declined 5.9% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Charles River capital expenditures compounded at +5.6% per year, with the latest reading among the more recent periods of the dataset.
Between 2022 and 2025, Charles River capital expenditures plunged 32.5%, falling from $324.73M to $219.15M.
The dataset's maximum capital expenditures sits at $324.73M (2022); the minimum reading of $11.91M dates to 1998.
Charles River (CRL) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $3.87B.
Charles River Capital Expenditures by Year
Charles River Capital Expenditures 2025: $219.15M
Charles River capital expenditures in 2025 was $219.15M, declined 5.9% below 2024.
Charles River Capital Expenditures 2024: $232.97M
Charles River capital expenditures in 2024 was $232.97M, declined 26.9% below 2023.
Charles River Capital Expenditures 2023: $318.53M
Charles River capital expenditures in 2023 was $318.53M, edged down 1.9% below 2022.
Charles River Capital Expenditures 2022: $324.73M
Charles River capital expenditures in 2022 was $324.73M, surged 41.9% from 2021. This figure represents the highest annual value in the available history.
Charles River Capital Expenditures 2021: $228.77M
Charles River capital expenditures in 2021 was $228.77M.
See more financial history for Charles River (CRL).
Sector peers — CapEx
Companies in the same sector as Charles River, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Charles River's capital expenditures?
- Latest reported capital expenditures for Charles River (CRL) is $219.15M (period ending December 27, 2025).
How has Charles River capital expenditures changed year-over-year?
- Charles River (CRL) capital expenditures changed -5.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Charles River capital expenditures?
- Charles River (CRL) capital expenditures compound annual growth rate is +5.6% over the most recent 5 years available.
When did Charles River capital expenditures hit its highest annual value?
- Charles River capital expenditures reached its highest annual value of $324.73M in 2022.
What was Charles River capital expenditures in 2024?
- Charles River (CRL) capital expenditures in 2024 was $232.97M.
What was Charles River capital expenditures in 2025?
- Charles River (CRL) capital expenditures in 2025 was $219.15M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
CRL Overview
Company profile, financial tools, and key metrics
CRL Revenue Counter
Earns $127.33 every second. See per minute, hour, and day.
CRL Earnings Counter
Loses −$4.58 per second. See per minute, hour, and day.
CRL Economic Scale
Exceeds Curacao's GDP. Compare with world economies.
CRL What If Invested
What if you had invested $1,000? See historical returns from any date.
CRL How It Makes Money
Discover visual breakdown of $4.02B in revenue — where it comes from and where it goes.
CRL Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
CRL Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
CRL Daily Price Character
Balanced · 51.7% historical win rate (green days). Streaks & record days.
CRL Buybacks
3.60% TTM buyback yield. Shareholder yield & SBC comparison.